Product Images Cisatracurium Besylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Cisatracurium Besylate NDC 70436-112 by Slate Run Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - image 01
This text likely refers to a change of 60% over 4 hours and represents variations around 60%. It may be showing a percentage increase or decrease over a specific timeframe.*
Figure 2 - image 02
10 mg per 5 mL vial - image 03
200 mg per 20 mL - image 04
This is a description for a pharmaceutical product labeled as NDC70436-11450, which is Cisatracurium Besylate Injection, USP. It is a paralyzing agent for intravenous use and each mL contains Cisatracurium 10mg equivalent to 13.3 mg of cisatracurium besylate. The warning mentions the potential paralysis of the respiratory system, requiring immediate availability of facilities for artificial respiration. The product should be stored at 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit) in the carton and used within 21 days once removed from refrigeration. Manufactured by Hainan Poly Pharmaceutical Co. and distributed by SilTé Pharmaceutic,LLC in Columbus, Ohio.*
chemical structure - image structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
